TITLE

Starter scrips would save time and money

AUTHOR(S)
Lancelot, Chris
PUB. DATE
May 2009
SOURCE
GP: General Practitioner;5/29/2009, p21
SOURCE TYPE
Periodical
DOC. TYPE
Opinion
ABSTRACT
In this article the author discusses the efficiency of the starter prescriptions as a cost saving measure for patients in Great Britain. It has been analyzed that indicating the total number of medicines to be taken for a week is efficient because the patient is not asked to make further payments in collecting the remaining prescriptions. This strategy is better compared to the weekly prescription wherein the patient is made to pay charges for every new medicine recommended.
ACCESSION #
41577657

 

Related Articles

  • Reference Pricing For Drugs: Is It Compatible With U.S. Health Care? Kanavos, Panos; Reinhardt, Uwe // Health Affairs;May/Jun2003, Vol. 22 Issue 3, p16 

    What can be learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies'...

  • Overview of Approaches to Control Prescription Drug Spending in Federal Programs.  // GAO Reports;6/24/2009, preceding p1 

    The article presents the assessments of the Government Accountability Office (GAO) on federal programs to control drug prescription spending in the U.S. It mentions various federal programs that control drug prescription spending such as Federal Employees Health Benefits Program (FEHBP),...

  • YOUR MONEY.  // Health (Time Inc.);Mar2007, Vol. 21 Issue 2, p98 

    The article presents question and answers related to personal finance. One person asks whether he should ask his doctor for a generic drug instead of a more expensive brand name drug when he needs a prescription. He is advised that he should since drug effectiveness experts have found that...

  • Public Reporting On Quality In The United States And The United Kingdom. Marshall, Martin N.; Shekelle, Paul G.; Davies, Huw T.O.; Smith, Peter C. // Health Affairs;May/Jun2003, Vol. 22 Issue 3, p134 

    Several recent bills in Congress to add a Medicare prescription drug benefit would allow the use of formularies to control costs. However, there is little empirical evidence of the impact of formularies among elderly and disabled populations. We assess the effect of a closed formulary...

  • NHS charges are a mess, say MPs. Cole, Andrew // BMJ: British Medical Journal (International Edition);7/22/2006, Vol. 333 Issue 7560, p163 

    The author reports that Great Britain's House of Commons Health Select Committee has recommended a complete reassessment of the system of charging for health services that may include eliminating prescription charges. The exemptions system that is supposed to be based on income actually exempts...

  • NHS pays too much for branded drugs. Mayor, Susan // BMJ: British Medical Journal (International Edition);2/24/2007, Vol. 334 Issue 7590, p383 

    The article presents the results of a British government report. The report, which was from the Office of Fair Trading, a body that protects consumers' interests in the United Kingdom, found that health services in the United Kingdom are overpaying approximately $980 million a year for...

  • Physician Communication Regarding Cost When Prescribing Asthma Medication to Children. Patel, Minal R.; Coffman, Janet M.; Chien-Wen Tseng; Clark, Noreen M.; Cabana, Michael D. // Clinical Pediatrics;Jun2009, Vol. 48 Issue 5, p493 

    Children with asthma require multiple medications, and cost may be a barrier to care. The purpose of this study was to determine how often physicians ask about cost when prescribing new asthma medication and to identify factors influencing queries. We surveyed pediatricians and family physicians...

  • Let's Rediscover Imagination. Bobo, Jack // National Underwriter / Life & Health Financial Services;11/25/2002, Vol. 106 Issue 47, p25 

    Comments on the reasons for the disparity of prescription drug prices between the United States and its neighboring countries. Areas of criticism about the price disparity issue; Requirement of more imagination and forbearance to find a solution to the problem.

  • International Experience With Prescription Drug Policy.  // Health Affairs;May/Jun2003, Vol. 22 Issue 3, p15 

    To control spending on prescription drugs, health insurance systems abroad have experimented in recent years with a novel form of patient cost sharing called "reference pricing." Under this approach, the insurer covers only the prices of Iow-cost, benchmark drugs in therapeutic clusters that are...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics